Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia

Crit Care Med. 2003 Apr;31(4 Suppl):S238-42. doi: 10.1097/01.CCM.0000057849.53689.65.

Abstract

Objectives: To review the involvement of coagulation and fibrinolysis in the pathogenesis of acute lung injury during severe infection. To review the cross-talk between coagulation and inflammation that may affect this response.

Data sources: Published articles on experimental and clinical studies of coagulation and fibrinolysis during infection, inflammation, acute lung injury, and evolving acute respiratory distress syndrome.

Conclusions: Fibrin deposition is an important feature of pulmonary infection or severe inflammation. The mechanisms that contribute to this fibrin deposition are bronchoalveolar tissue factor-mediated thrombin generation and localized depression of urokinase plasminogen activator-mediated fibrinolysis, caused by the increase of plasminogen activator inhibitors. These effects on pulmonary coagulation and fibrinolysis are regulated by various proinflammatory cytokines. Rather than being a unidirectional relationship, the interaction between inflammation and coagulation involves significant cross-talk. Coagulation and fibrinolytic proteins may have an additional role beyond fibrin turnover and inflammation, e.g., in mechanisms mediating cell recruitment and migration.

Publication types

  • Review

MeSH terms

  • Bronchoalveolar Lavage Fluid
  • Cytokines / physiology*
  • Endotoxemia / metabolism
  • Endotoxemia / physiopathology*
  • Fibrin / metabolism
  • Fibrinolysis / physiology*
  • Humans
  • Pneumonia / metabolism
  • Pneumonia / physiopathology*
  • Respiratory Distress Syndrome / metabolism
  • Respiratory Distress Syndrome / physiopathology*
  • Thromboplastin / metabolism
  • Thromboplastin / physiology*

Substances

  • Cytokines
  • Fibrin
  • Thromboplastin